1-Palmitoyl-2-linoleoyl-sn-glycero-3-PC
Based on 1 Customer Validation
1-Palmitoyl-2-linoleoyl-sn-glycero-3-PC (PLPC) is a phosphatidylcholine phospholipid. 1-Palmitoyl-2-linoleoyl-sn-glycero-3-PC and oxidized derivatives serve as models for investigating lipid peroxidation, membrane structure, and phospholipase A2 activity. 1-Palmitoyl-2-linoleoyl-sn-glycero-3-PC can be applied in research on atherosclerosis, oxidative stress, and the properties of lipid bilayers.
For research use only. We do not sell to patients.
- Purity : 99.0%
- CAS No.: 17708-90-6
- Formula: C42H80NO8P
- Molecular Weight:758.06
-
Storage:
Solution, -20°C, 2 years
Biological Activity
Description
In Vitro
1-Palmitoyl-2-linoleoyl-sn-glycero-3-PC (PLPC) (20 min hydration, 30 min vacuum drying, 30 min centrifugation) exhibits characteristic fluid membrane acyl chain order and a baseline 28% H2-bonded nitroxide population in the bilayer central region, with an Azz polarity parameter of 3.28 mT[1].
1-Palmitoyl-2-linoleoyl-sn-glycero-3-PC shows no change in sub-headgroup region polarity/proticity at cryogenic temperatures, while the bilayer central region has a 28% H-bonded nitroxide population[1].
1-Palmitoyl-2-linoleoyl-sn-glycero-3-PC (0.75 mg/mL LDL; 0.5-7 h) undergoes free radical oxidation in human LDL resulting in time-dependent formation of PLPC hydroperoxides and alcohols, with nearly 15% of endogenous PLPC oxidized after 7 h; α-tocopherol is less effective at inhibiting PLPC oxidation in the LDL surface layer[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 17708-90-6
-
Appearance Liquid
-
Molecular Weight 758.06
-
Formula C42H80NO8P
-
Color Colorless to light yellow
-
SMILES
CCCCC/C=C\C/C=C\CCCCCCCC(O[C@H](COC(CCCCCCCCCCCCCCC)=O)COP(OCC[N+](C)(C)C)([O-])=O)=O
-
Synonyms
PLPC
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Solution, -20°C, 2 years
Protocols
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Research Protocol for Cardiovascular Diseases
Cardiovascular disease can be modeled as maladaptive cardiac remodeling, where ischemic injury or pressure overload activates inflammatory signaling, fibroblast activation, extracellular-matrix deposition, cardiomyocyte hypertrophy, vascular remodeling, and progressive ventricular dysfunction. The TGF-β/SMAD axis is a central profibrotic pathway after myocardial injury and pressure overload, while innate immune and cytokine pathways regulate leukocyte recruitment, scar formation, and adverse remodeling. Key unresolved questions include which inflammatory signals are reparative versus harmful, when fibrosis is protective versus maladaptive, and whether pathway inhibition improves function without weakening necessary infarct healing or compensatory remodeling.
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
Purity & Documentation
-
Data Sheet (266 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
[1]. Conte E, et al. Lipid peroxidation and water penetration in lipid bilayers: a W-band EPR study. Biochimica et biophysica acta. 2013 Feb;1828(2):510-7. [Content Brief]
[2]. Høyrup P, et al. Phospholipase A(2) activity towards vesicles of DPPC and DMPC-DSPC containing small amounts of SMPC. Biochimica et biophysica acta. 2001 Dec 01;1515(2):133-43. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- 1-Palmitoyl-2-linoleoyl-sn-glycero-3-PC
- 17708-90-6
- PLPC
- Liposome
- phosphatidylcholine phospholipid
- low-density lipoprotein
- cholesteryl linoleate
- 5-doxylstearoyl-phosphatidylcholine
- lipid bilayers
- free radical oxidation
- 13-hydroperoxides
- multilamellar vesicles
- atherosclerosis
- lipid peroxidation intermediates
- Inhibitor
- inhibitor
- inhibit